Form 4: Blackstone Entities Reduce Medline Stake

Blackstone-affiliated entities, including Mozart Aggregator II LP, sold and distributed significant shares of Medline Inc. Class A and Class B common stock and common units.

Summary

• Mozart Aggregator II LP sold 13,462,600 shares of Medline Inc. Class A Common Stock at a net price of $28.3683 per share on December 18, 2025.
• Mozart Aggregator II LP also initiated in-kind distributions of 268,536 shares of Class A Common Stock to one of its investors and certain affiliated entities on December 18, 2025.
• BCP Mozart Aggregator L.P. disposed of 6,954,440 shares of Class B Common Stock and 6,954,440 Common Units of Medline Holdings, LP on December 18, 2025.
• The Class B Common Stock has no economic value and was automatically cancelled upon the sale of equivalent Common Units.
• Common Units of Medline Holdings, LP are exchangeable for Class A Common Stock on a one-for-one basis and these exchange rights do not expire.
• The net sale price of $28.3683 per share was derived from a secondary public offering price of $29.00 per share, less an underwriting discount of $0.63173 per share.
• Following these transactions, Mozart Aggregator II LP indirectly holds 142,918,680 Class A Common Stock, and BCP Mozart Aggregator L.P. indirectly holds 72,372,632 Class B Common Stock and 11,724 Class A Common Stock.
• Multiple Blackstone-affiliated entities and Stephen A. Schwarzman are listed as reporting persons, each disclaiming beneficial ownership except to the extent of their pecuniary interest.

Sentiment

Score: 4

Explanation: The filing reports a significant sale of shares by a major institutional investor and director, which can be viewed negatively as a reduction in their stake. However, it's part of a secondary public offering, indicating a planned liquidity event rather than an unexpected divestment, which mitigates some negative sentiment.

Positives

• The transactions represent a significant liquidity event for the selling Blackstone-affiliated entities.
• An increase in the public float of Medline Inc. Class A Common Stock could enhance market liquidity and accessibility for other investors.

Negatives

• A substantial reduction in ownership by a major institutional investor (Blackstone) and a 10% owner/Director could be perceived as a lack of conviction or a strategic exit.
• The sale of a large block of shares could potentially exert downward pressure on Medline Inc.'s stock price in the short term due to increased supply.

Risks

• The significant sale by a major investor might signal a perceived plateau in Medline Inc.'s growth or value, potentially influencing other investors' sentiment.
• Future sales by the remaining Blackstone-affiliated entities, once lock-up agreements expire, could create additional supply in the market, potentially impacting share price.
• The in-kind distributions of Class A Common Stock to investors are subject to the restrictions set forth in the Lock Up Agreement, limiting immediate resale.

Future Outlook

The in-kind distributions to investors are subject to the restrictions set forth in the Lock Up Agreement, indicating a future period during which these specific shares cannot be freely traded.

Industry Context

This Form 4 filing primarily details insider transactions and does not provide broader industry trends or competitive analysis for Medline Inc.

Related Party Transactions

• The reported transactions involve sales and distributions of Medline Inc. securities by Blackstone-affiliated entities, which are identified as 10% owners and directors of the issuer, making these related party transactions.

Stakeholder Impact

• Shareholders may experience increased market liquidity due to the larger public float of Class A Common Stock.
• The significant sale by a major investor could lead to short-term price volatility or a re-evaluation of the company's prospects by other investors.
• The Blackstone-affiliated entities have achieved a liquidity event for a portion of their investment in Medline Inc.

Next Steps

• The distributees of the in-kind Class A Common Stock distributions have agreed to be bound by the restrictions of the Lock Up Agreement, implying a period of restricted trading for those shares.

Key Dates

Recommendation

A substantial sale by a major institutional investor and director warrants a cautious approach. While it provides liquidity for the seller, it also reduces their direct stake in the company. Investors should hold and monitor Medline's performance and future disclosures for further insights into the company's strategic direction and the rationale behind such a significant divestment by a key shareholder.

Keywords

Medline, MDLN, Blackstone, Mozart Aggregator, SEC Form 4, Insider Transaction, Stock Sale, Secondary Offering, Private Equity, Beneficial Ownership